Ondine Biomedical Stock Debt To Equity
| OBI Stock | 7.75 0.25 3.12% |
Ondine Biomedical fundamentals help investors to digest information that contributes to Ondine Biomedical's financial success or failures. It also enables traders to predict the movement of Ondine Stock. The fundamental analysis module provides a way to measure Ondine Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ondine Biomedical stock.
Ondine | Debt To Equity |
Ondine Biomedical Company Debt To Equity Analysis
Ondine Biomedical's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
Ondine Total Stockholder Equity
Total Stockholder Equity |
|
According to the company disclosure, Ondine Biomedical has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The debt to equity for all United Kingdom stocks is 100.0% higher than that of the company.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Ondine Fundamentals
| Return On Equity | -6.86 | ||||
| Return On Asset | -1.6 | ||||
| Operating Margin | (9.12) % | ||||
| Current Valuation | 33.62 M | ||||
| Shares Outstanding | 426.23 M | ||||
| Shares Owned By Insiders | 46.89 % | ||||
| Shares Owned By Institutions | 23.96 % | ||||
| Price To Book | 3,237 X | ||||
| Price To Sales | 20.22 X | ||||
| Revenue | 1.2 M | ||||
| Gross Profit | 1.25 M | ||||
| EBITDA | (13.79 M) | ||||
| Net Income | (14.41 M) | ||||
| Total Debt | 541 K | ||||
| Cash Flow From Operations | (13.65 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Target Price | 60.0 | ||||
| Beta | -0.08 | ||||
| Market Capitalization | 33.03 M | ||||
| Total Asset | 5.73 M | ||||
| Retained Earnings | (266.33 M) | ||||
| Working Capital | 1.26 M | ||||
| Net Asset | 5.73 M |
About Ondine Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ondine Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ondine Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ondine Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ondine Stock
Ondine Biomedical financial ratios help investors to determine whether Ondine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ondine with respect to the benefits of owning Ondine Biomedical security.